← Leaderboards
Timothy R Donahue
University Of California Los Angeles
$4,604,839
Attributed
$12,773,301
Total exposure
6
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2M · FY2014–25$2M$1.5M$1M$500K$0
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$12,773,301 · 6
By mechanism
R01$10,217,212 · 4
U01$2,377,645 · 1
T32$178,444 · 1
Top collaborators
- Caius Gabriel Radu19 shared
- Zev A Wainberg7 shared
- Johannes Czernin5 shared
- Huan Meng5 shared
- Andre Elias Nel5 shared
- Jeffrey I Zink5 shared
- Manuel L Penichet1 shared
Most similar at University Of California Los Angeles
Same institution · by research overlap
- Caius Gabriel Radu$8,088,566
- Jing Wen$2,923,926
- Zev A Wainberg$1,430,425
- Arjun Deb$19,563,654
- Heather Christofk$9,647,151
Others in their field
Top investigators on “Pancreatic Ductal Adenocarcinoma”
- Anirban Maitra · Johns Hopkins University$27,617,954
- Ronald Anthony Depinho · University Of Tx Md Anderson Can Ctr$17,689,051
- Sunil R Hingorani · Fred Hutchinson Cancer Research Center$15,005,509
- David Tuveson · University Of Pennsylvania$13,334,563
- Channing J Der · University Of North Carolina Chapel Hill$12,699,348
- David G Denardo · Washington University$12,568,412
Research focus
Pancreatic Ductal AdenocarcinomaMetabolismMalignant Neoplasm Of PancreasMalignant NeoplasmsTumorResistanceMass Spectrum AnalysisNeoplastic CellPathway InteractionsMetabolicTumor MicroenvironmentMediatingSignal TransductionNucleotide MetabolismMouse ModelProductionClinical TrialsPancreatic Ductal Adenocarcinoma ModelSolid NeoplasmUptakeResponsePreventImmune Checkpoint BlockadeNucleotides
Grant awards (25)
Causes and Consequences of Adenosine Signaling in Pancreatic Cancer$653,625
R01 · FY2025 · CA · contact PI
Targeting KRAS and adenosine mediated immunosuppression in pancreatic cancer$585,317
R01 · FY2025 · CA
Leveraging Vulnerabilities Induced by STING Activation in Pancreatic Cancer$572,887
R01 · FY2025 · CA · contact PI
UCLA Surgeon-Scientist Basic Cancer Research Training Program (UCLA Surgeon-Scientist BCRTP)$178,444
T32 · FY2025 · CA · contact PI
Causes and Consequences of Adenosine Signaling in Pancreatic Cancer$653,452
R01 · FY2024 · CA · contact PI
Leveraging Vulnerabilities Induced by STING Activation in Pancreatic Cancer$575,892
R01 · FY2024 · CA · contact PI
Targeting KRAS and adenosine mediated immunosuppression in pancreatic cancer$567,204
R01 · FY2024 · CA
Targeting KRAS and adenosine mediated immunosuppression in pancreatic cancer$590,100
R01 · FY2023 · CA
Leveraging Vulnerabilities Induced by STING Activation in Pancreatic Cancer$565,439
R01 · FY2023 · CA · contact PI
Leveraging Vulnerabilities Induced by STING Activation in Pancreatic Cancer$48,151
R01 · FY2023 · CA · contact PI
Targeting KRAS and adenosine mediated immunosuppression in pancreatic cancer$607,124
R01 · FY2022 · CA
Leveraging Vulnerabilities Induced by STING Activation in Pancreatic Cancer$602,783
R01 · FY2022 · CA · contact PI
Leveraging Vulnerabilities Induced by STING Activation in Pancreatic Cancer$96,857
R01 · FY2022 · CA · contact PI
Targeting KRAS and adenosine mediated immunosuppression in pancreatic cancer$634,454
R01 · FY2021 · CA
Leveraging Vulnerabilities Induced by STING Activation in Pancreatic Cancer$630,802
R01 · FY2021 · CA · contact PI
UCLA Multifunctional Mesoporous Silica Nanoparticle Platform for Treatment of Pancreas Cancer$433,388
U01 · FY2019 · CA
PET Imaging-guided Personalized Therapy in Pancreatic Cancer$585,018
R01 · FY2018 · CA
UCLA Multifunctional Mesoporous Silica Nanoparticle Platform for Treatment of Pancreas Cancer$459,169
U01 · FY2018 · CA
PET Imaging-guided Personalized Therapy in Pancreatic Cancer$585,018
R01 · FY2017 · CA
UCLA Multifunctional Mesoporous Silica Nanoparticle Platform for Treatment of Pancreas Cancer$476,683
U01 · FY2017 · CA
PET Imaging-guided Personalized Therapy in Pancreatic Cancer$585,018
R01 · FY2016 · CA
UCLA Multifunctional Mesoporous Silica Nanoparticle Platform for Treatment of Pancreas Cancer$495,258
U01 · FY2016 · CA
PET Imaging-guided Personalized Therapy in Pancreatic Cancer$559,454
R01 · FY2015 · CA
UCLA Multifunctional Mesoporous Silica Nanoparticle Platform for Treatment of Pancreas Cancer$513,147
U01 · FY2015 · CA
PET Imaging-guided Personalized Therapy in Pancreatic Cancer$518,617
R01 · FY2014 · CA